Home / Charity no. 1068395
LYMPHOMA ACTION
Registered charity · Buckingh
Banded public disclosure
What is LYMPHOMA ACTION's CEO salary?
No highest-paid staff band is available in the data held for this profile. That does not prove that every employee was paid below the reporting threshold; check the latest accounts and official register entry before drawing a conclusion.
Check the official record and filed accounts →To ensure that those affected by lymphomas have access to relevant, accurate and timely information and support.
Annual income
£2,863,035
Annual expenditure
£2,487,482
Trustees
—
Income and spending explained
Spending as a share of income
86.9%
Income less expenditure
£375,553
These are simple calculations from the reported figures, not an efficiency rating. A surplus or deficit in one period can reflect restricted funds, grants, reserves, capital projects or timing. Read the latest filed accounts before drawing a conclusion.
- Public contact address
- Lymphoma Action, Unit 3, Bell Business Park, Smeaton Close, AYLESBURY, Buckingh
- Registered
- 2 March 1998
- Financial year end
- 31 December 2025
Questions about this charity's finances
What is LYMPHOMA ACTION's CEO salary?
No highest-paid staff benefits band is available in the data held for LYMPHOMA ACTION. That is not evidence that the CEO was unpaid or that every employee was below the reporting threshold; the charity's filed accounts are the appropriate source for a named role.
How much income and spending did LYMPHOMA ACTION report?
LYMPHOMA ACTION reported annual income of £2,863,035 and annual expenditure of £2,487,482 for the financial period shown on this page. These figures should be read with the filed accounts.
Is LYMPHOMA ACTION financially efficient?
These register figures cannot answer that on their own. Restricted funds, grants, reserves, capital spending, the charity's purpose and its reporting period all affect the numbers. This site does not turn them into an efficiency score.
Source: Charity Commission register entry · Bulk register extract dated 4 September 2026